Bill116th CongressFiled May 20, 2019
H.R. 2855
To deem the application submitted by Jaci Hermstad to the Food and Drug Administration for compassionate use of the gene therapy antisense oligonucleotides to be approved.
Bill journey · stage 2 of 5
Under committee review
FiledFiled
CommitteeComm.
PassedFloor
Both ChambersBoth
Became LawLaw
What it doesSummary introduced in house (May 20, 2019)
This bill provides for approval of the application submitted by Jaci Hermstad to the Food and Drug Administration for compassionate use of the gene therapy antisense oligonucleotides.
What just happenedMay 21, 2019
Referred to the Subcommittee on Health.
Who’s behind it
Rep. King, Steve [R-IA-4](R-IA)Sponsor
1committees4actions1subjects
- Introduced in HouseMay 20, 2019
- May 21, 2019Committee
Referred to the Subcommittee on Health.
Health Subcommittee - May 20, 2019IntroReferralH11100
Referred to the House Committee on Energy and Commerce.
Energy and Commerce Committee - May 20, 2019IntroReferralIntro-H
Introduced in House
- May 20, 2019IntroReferral1000
Introduced in House